2015
DOI: 10.4236/cmb.2015.52004
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Docking Studies of Myricetin and Its Analogues against Human PDK-1 Kinase as Candidate Drugs for Cancer

Abstract: Phosphoinositide-dependent protein kinase-1 (PDK1), the class of serine threonine kinase, is a master regulator of the AGC family of kinases. It is a main component of the PI3K pathway. As it is reported that this pathway is most commonly, and this pathway is the most commonly deregulated among many cancers. So designing a selective inhibitor of PDK1 may have the efficacy as an anticancer agent. Herein, we describe our work focused on the structure based on screening of 95% similar analogues of Myricetin depos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties have a predictable influence on pharmacokinetic and pharmacodynamic effects of drug molecules. The calculation of ADMET properties is therefore intended as the first step towards optimising the new drug molecules, whether to check the failure of lead molecules which may cause toxicity and one unable to cross the intestinal membranes or metabolised by the body in to an inactive form 16 .…”
Section: Introductionmentioning
confidence: 99%
“…ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties have a predictable influence on pharmacokinetic and pharmacodynamic effects of drug molecules. The calculation of ADMET properties is therefore intended as the first step towards optimising the new drug molecules, whether to check the failure of lead molecules which may cause toxicity and one unable to cross the intestinal membranes or metabolised by the body in to an inactive form 16 .…”
Section: Introductionmentioning
confidence: 99%
“…Most of the drug disappointments have been reported in early and late pipeline stages due to the undesired pharmacokinetics and toxicity problems [23]. If these questions are resolved early, it would be exceptionally beneficial for the drug discovery process.…”
mentioning
confidence: 99%
“…The 95 % confidence ellipse represents the region of chemical space with molecules having excellent absorption through cell membrane. According to this model, for a designed molecule to have an optimal cell permeability, it should follow the criteria of PSA < 140 Å 2 and AlogP98 < 5) [ 24 ]. The selected 35 molecules have shown PSA < 140 Å 2 and AlogP98 < 5 which satisfied the criteria.…”
Section: Resultsmentioning
confidence: 99%